Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(S)-2-amino-3-(1,3,5,7-pentahydro-2.4-dioxo-cyclopenta[e]pyrimidin-l-yI)propanoic acid is a synthetic small molecule structurally related to amino acids and pyrimidine derivatives. It is primarily used as an experimental tool compound in biochemical and pharmacological research. The compound has been studied for its interaction with glutamate receptors—specifically the GluR subtypes—where it acts as a ligand or modulator in receptor binding studies[8]. Its mechanism of action involves mimicking or interfering with endogenous amino acid neurotransmitters at excitatory synapses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (S)-2-amino-3-(1,3,5,7-pentahydro-2,4-dioxo-cyclopenta[e]pyrimidin-1-yl)propanoic acid.